Structure-activity relationships of Bak derived peptides: Affinity and specificity modulations by amino acid replacement

被引:11
作者
Frey, Virginie [1 ,2 ,3 ]
Viaud, Julien [1 ,2 ,3 ]
Subra, Guy [1 ,2 ,3 ]
Cauquil, Nicolas [4 ]
Guichou, Jean-Francois [1 ,2 ,3 ]
Casara, Patrick [4 ]
Grassy, Gerard [1 ,2 ,3 ]
Chavanieu, Alain [1 ,2 ,3 ]
机构
[1] INSERM, U554, F-34090 Montpellier, France
[2] Univ Montpellier 1, CNRS, UMR5048, Ctr Biochim Struct, F-34090 Montpellier, France
[3] Univ Montpellier 2, CNRS, UMR5048, Ctr Biochim Struct, F-34090 Montpellier, France
[4] Inst Rech Servier, F-78290 Croissy Sur Seine, France
关键词
apoptosis; Bcl-X(L); Bcl-2; structure-activity relationships; selectivity;
D O I
10.1016/j.ejmech.2007.06.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To study the structure-activity relationships (SAR) and the binding activity of pro-apoptotic Bak BH3 domain, we synthesised several 16mer peptide analogues corresponding, to the region (72)-GQVGRQLAIIGDDINR-(87). Using different amino acids varying in length, steric and electronic properties, we investigated the role and the nature of physicochemical parameters of residues Val74, Leu78, I1e81 and Ile85, previously identified to be crucial for interactions. With this aim, we measured the affinity of these peptides on two anti-apoptotic proteins Bcl-x(L) and Bcl-2 by a polarization fluorescence competitive assay. We defined that the most potent peptide on Bcl-X(L), which presents a 4.6-fold increase as compared to the parent peptide affinity, was obtained when Ile85 was mutated with a 4-chlorophenylaianine. Finally, assays of eight Bak peptide analogues on Bcl-2 allowed us to postulate that modulations at position 78 could afford peptides with a binding selectivity enhanced for BCl-X(L). These pharmacological and physicochemical parameter data should prove useful for the rational design of non-peptide ligands as potential antagonists of Bcl-2 protein interactions. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:966 / 972
页数:7
相关论文
共 37 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] QUANTITATIVE-ANALYSIS OF PROTEIN FAR UV CIRCULAR-DICHROISM SPECTRA BY NEURAL NETWORKS
    BOHM, G
    MUHR, R
    JAENICKE, R
    [J]. PROTEIN ENGINEERING, 1992, 5 (03): : 191 - 195
  • [3] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
    Bruncko, Milan
    Oost, Thorsten K.
    Belli, Barbara A.
    Ding, Hong
    Joseph, Mary K.
    Kunzer, Aaron
    Martineau, Darlene
    McClellan, William J.
    Mitten, Michael
    ng, Shi-Chu Ng
    Nimmer, Paul M.
    Oltersdorf, Tilman
    Park, Cheol-Min
    Petros, Andrew M.
    Shoemaker, Alexander R.
    Song, Xiaohong
    Wang, Xilu
    Wendt, Michael D.
    Zhang, Haichao
    Fesik, Stephen W.
    Rosenberg, Saul H.
    Elmore, Steven W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 641 - 662
  • [4] Regulation of apoptosis by Bcl-2 family proteins
    Burlacu, A
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) : 249 - 257
  • [5] Proteins of the Bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities
    Chan, SL
    Yu, VC
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (03): : 119 - 128
  • [6] A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS
    CHITTENDEN, T
    FLEMINGTON, C
    HOUGHTON, AB
    EBB, RG
    GALLO, GJ
    ELANGOVAN, B
    CHINNADURAI, G
    LUTZ, RJ
    [J]. EMBO JOURNAL, 1995, 14 (22) : 5589 - 5596
  • [7] COULSON DR, 1982, INORG SYNTH
  • [8] Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
    Degterev, A
    Lugovskoy, A
    Cardone, M
    Mulley, B
    Wagner, G
    Mitchison, T
    Yuan, JY
    [J]. NATURE CELL BIOLOGY, 2001, 3 (02) : 173 - 182
  • [9] Diaz JL, 1997, J BIOL CHEM, V272, P11350
  • [10] Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-x(L)
    Kelekar, A
    Chang, BS
    Harlan, JE
    Fesik, SW
    Thompson, CB
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) : 7040 - 7046